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We have conducted a systematic review of air embolism complications of neurosurgery in the
sitting position and patent foramen ovale (PFO) closure. It assesses the risk and benefit of
PFO closure before neurosurgery in the sitting position. The databases Medline, Embase, and
Cochrane Controlled Trial Register were systematically searched from inception to November
2007 for keywords in both topics separately. In total, 4806 patients were considered for neuro-
surgery in sitting position and 5416 patients underwent percutaneous PFO closure. The overall
rate of venous air embolism during neurosurgery in sitting position was 39% for posterior
fossa surgery and 12% for cervical surgery. The rate of clinical and transoesophageal echocar-
diography detected paradoxical air embolism was reported between 0% and 14%. The overall
success rate for PFO closure using new and the most common closure devices was reported
99%, whereas the average risk of major complications is ,1%. On the basis of our systematic
review, we recommend screening for PFO and considering closure in cases in which the sitting
position is the preferred neurosurgical approach. Our proposed management including the
time of PFO closure according to available data is presented. However, the conclusions from
our systematic review may be limited due to the lack of level A evidence and from using data
from observational cohort studies. Thus, definite evidence-based recommendations require
prospective evaluation of the issue in well-designed studies.
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Fatal air embolism in a patient operated on in the sitting
position was first reported by Barlow9 in 1830, and the
sitting position in brain and cervical spine surgery has been
a subject of interest since then.30 37 85 90 During this time,
expert opinion has been revised repeatedly. The sitting
position has advantages but also has intrinsic compli-
cations.73 85 The most severe risks are venous air embolism
(VAE) and its potentially fatal complication, paradoxical
air embolism (PAE).32 52 79 90 VAE is defined as the
entrainment of air (or exogenously delivered gas) into the
venous system from the operative site or another communi-
cation with the environment. It may produce a broad array
of systemic effects and outcomes. PAE occurs when VAE
passes into the systemic arterial circulation, for example,
through a patent foramen ovale (PFO). A negative pressure
in cranial veins in the sitting position leads to air aspiration.
However, a lower incidence of VAE during neurosurgery
has also been reported in the horizontal position.2 19 42 92 99
VAE may have catastrophic cardiovascular, pulmonary,
and neurological sequelae regardless of the presence of a
PFO. A PFO is the major mechanism for cerebral
arterial air embolism during neurosurgery in that situ-
ation.37 38 59 69 85 87 89 Its prevalence in the normal popu-
lation is about 25%,56 and .40% in adults with
cryptogenic stroke.72
The presence of a PFO represents a significant contraindi-
cation to neurosurgery in the sitting position, and many sur-
geons avoid the sitting position in order to minimize the risk
of PAE.19 37 45 49 52 74 76 90 96 Therefore, transoesophageal
echocardiography (TOE) or transcranial Doppler ultrasound
has become a routine preoperative evaluation in many
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centres to rule out a PFO in such patients.52 70 74 85 90 95
However, neurosurgery in the sitting position cannot always
be avoided in this population, as some neurosurgeons feel
uncomfortable with the horizontal position for certain oper-
ations and are prepared to accept the increased risk for
PAE.19 94 Meanwhile, percutaneous PFO closure using dedi-
cated devices has become a routine procedure with a low
risk and high success rate.116
The indications of preoperative PFO closure in order to
minimize the risk for neurosurgery in the sitting position
remain to be defined.
The aim of this systematic review is to assess the risk
and benefit of PFO closure before neurosurgery in the
sitting position.
Literature search
Two groups were defined for the literature review: Group
1, studies of air embolism during neurosurgical procedures
in sitting position, and Group 2, percutaneous PFO closure
studies. The databases Medline, Embase, and Cochrane
Controlled Trial Register were systematically searched
from inception to November 2007 by various combi-
nations of the keyword groups: (i) neurosurgery, sitting
position, air embolism, complications, patent foramen
ovale and (ii) patent foramen ovale, persistent foramen
ovale, PFO, and closure. All abstracts were screened
according to the research question. Bibliographies of ident-
ified articles and reviews in this field were also searched.
Additionally, hand searching of pertinent journals for
issues in the last 6 months was undertaken. Articles in
multiple languages were searched.
Inclusion criteria for Group 1 were cohort studies with 10
or more patients undergoing neurosurgical procedures in the
sitting position with reporting of episodes of VAE or PAE.
Inclusion criteria for Group 2 were cohort studies including
10 or more patients undergoing percutaneous PFO closure
for any reason with follow-up of at least 3 months. The
reports including both PFO and atrial septal defect (ASD)
closures were included when the data were stratified for PFO
and ASD closures. Exclusion criteria for both groups were
studies of exclusively paediatric patients, experimental
studies, animal studies, case reports, expert opinions,
repeated reports from individual centres (the last all-inclus-
ive report was used), and studies with unclear methods.
Data extraction and analysis
Database search and data extraction were performed inde-
pendently by two authors and resulted in 127 abstracts
meeting the inclusion and exclusion criteria for Group 1
and 89 for Group 2. After full-text analysis, 28 remained
in Group 1 and 33 in Group 2. All were in English, except
for two papers in French. Quality was independently
assessed by two reviewers (A.-R.F. and P.E.) and differ-
ences were reconciled by mutual agreement of the senior
author (B.M.). The following data were tabulated from
included studies and inserted into a standardized excel
sheet (Microsoft Office 2000, Microsoft, Redmond, WA,
USA). Groups 1 and 2: author, publication year, journal,
language, study design, number of cases, mean age of
patients. Group 1: type of neurosurgical procedure, rates of
VAE and PAE, method of air embolism detection, screen-
ing for PFO, PFO prevalence, author recommendations
regarding PFO, and neurosurgery in the sitting position.
Group 2: PFO closure reasons, PFO closure devices, pro-
cedural success rates, major and minor peri-procedural
complication rates, and residual shunt rates. Comparison
of clinical outcome of air embolism was not feasible due
to clinical heterogeneity between studies with regard to
populations, interventions, form of outcome assessment, or
study method. The data were pooled using Comprehensive
Meta-analysis Version 2, Biostat, Englewood, NJ, USA
(2005), when it was feasible, and there was no heterogen-
eity in definitions or methodologies.
Definitions
The definitions of PAE and VAE were given above. The
most frequently used methods were TOE, precordial
Doppler study, and end-tidal CO2 (E
0
CO2
). PFO closure
success rates were defined as successful device implan-
tation. Minor procedural complications were haematoma or
bleeding not requiring transfusion, transient atrial arrhyth-
mia or atrioventricular node block, device embolization, air
embolization, transient ST-segment elevation, or femoral
arteriovenous fistula. Major complications were death,
stroke, cardiac tamponade, emergency surgery, haematoma,
or bleeding requiring blood transfusion or surgery, transient
ischaemic attack, significant (persistent) arrhythmia,
cardiac perforation, device malposition, septicaemia, myo-
cardial infarction, and massive pulmonary embolism.
Results
No randomized controlled trial or studies with level A evi-
dence were found. Therefore, we included both retrospec-
tive and prospective clinical cohort studies (evidence level
B of American Academy of Family Physicians).104
VAE and PAE in sitting position
Twenty-eight studies published between 1972 and 2007
were included for data analysis.2 3 15 18 19 25 33 38 42 47 52
53 70 71 75 77 79 81 84 87 92 97 99 103 107 109 115 120 In total,
4806 patients were included (Supplementary Table S1 in
online version). Fifty-four per cent of the studies were
prospective, six reported on VAE rates during posterior
fossa surgery alone, two during cervical procedures
alone, and 21 reported on both procedures. No study
evaluated the occurrence of PAE for either procedure sep-
arately. The overall occurrence of VAE ranged from 0%
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to 76% irrespective of the method of detection and pos-
ition. The incidence of VAE derived from pooled data
was 1–76% in the sitting position and 0–12% in the
horizontal position. The incidence of VAE from the
studies comparing two positions was 28.4% (15–45%)
(95% CI, 20.3–38.0) sitting and 5.5% (0–12%) (95% CI,
2.6–11.3) horizontal (Table 1). The rate of VAE was
38.6% (7–76%) (95% CI, 30.5–47.4) in posterior fossa
surgery and 11.8% (2–35%) (95% CI, 6.7–19.9) in cer-
vical procedures (Table 2). In the studies included,
patients were screened before operation for the presence
of PFO in 10 (36%) studies, and seven of them published
their prevalence. A PFO was detected in 5–33% of the
neurosurgical patients. Overall, 10 studies considered the
presence of PFO as an absolute contraindication for the
sitting position and patients were operated in the horizon-
tal position. Two of the 28 studies did not consider the
presence of PFO, if known, as a contraindication for neu-
rosurgery in the sitting position. Of note, none of the
studies mentioned the possibility of preoperative PFO
closure. The rate of clinical and TOE detected PAE was
reported in 20 of 28 studies (0214%, 0% in 14 studies).
Of the 28 studies included, TOE was used as a detection
method in nine. In three studies, the presence of a PFO
was not regarded as a contraindication to neurosurgery in
the sitting position (or at least not mentioned as a
contraindication). In these three studies, VAE was found
in 38%, 43%, and 60% and PAE in 14%, 0%, and 6.6%
of the study population, respectively (the one with 0%
PAE had partly excluded patients with PFO).
Patent foramen ovale
Thirty-three non-randomized studies published between
1992 and 2007, 19 prospective and 14 retrospective, were
included for data analysis (Supplementary Table S2 in
online version).1 6–8 11–13 21–24 27 28 31 40 41 44 46 60 61 63–66
80 86 91 93 101 105 106 111 116 In total, 5416 patients were
included. The cohorts ranged from 10 to 1006 patients and
the mean age of the patients from 30 to 57 yr. More than
80% of PFO closures were performed as a secondary pre-
vention for paradoxical embolism in patients with at least
one documented thromboembolic event. The remaining
indications were mostly migraine and diving. PFO closure
devices were ASDOS, Rashkind, Sideris, Buttoned Device,
Double-Umbrella, Angel Wing, PFO-Star, Amplatzer ASD
occluder, Amplatzer PFO occluder, CardioSEAL family
(including Clamshell and STAR-Flex), Cardia PFO occlu-
der (including IntraSept), Premere, Cierra, and Helex.
Amplatzer PFO occluder, CardioSEAL family, and
PFO-Star family were the most common devices. The prin-
ciple of percutaneous PFO closure is shown in Figure 1.
Table 1 Comparison of the rate of VAE between sitting position and horizontal position
Authors Year of publication VAE in SP VAE in HP Method of detection
Albin and colleagues 1976 25% 11% PD
Black and colleagues 1988 45% 12% PD
Duke and colleagues 1998 28% 5% E0CO2 and PD
Rath and colleagues 2007 15% 1% E0CO2
Schwarz and colleagues 1994 27% 0% E0CO2 and PD
Overall 28.4% (95% CI, 20.3–38.0) 5.5% (95% CI, 2.6–11.3)
Table 2 Comparison of the rate of VAE between posterior fossa surgery and cervical surgery in sitting position
Authors Year of publication VAE in posterior fossa surgery VAE in cervical surgery
Michenfelder and colleagues 1972 42% 24%
Albin and colleagues 1976 25%
Buckland and Manners 1976 33%
Cucchiara and colleagues 1984 60% TOE
Standefer and colleagues 1984 7%
Matjasko and colleagues 1985 41% 9%
Young and colleagues 1986 43% 13%
Black and colleagues 1988 45%
Losasso and colleagues 1992 43% 7%
Papadopoulos and colleagues 1994 76% 25% TOE
Simo Moyo and colleagues 1995 31%
Duke and colleagues 1998 28%
Stendel and colleagues 2000 75% 35% TOE
Schmitt and Hemmerling 2002 72% TOE
Girard and colleagues 2003 2%
Bithal and colleagues 2004 28%
Leslie and colleagues 2006 15% 6%
Overall 38.6% (95% CI, 30.5–47.4) 11.8% (95% CI, 6.7–19.9)
Overall of studies with TOE 73.7% (95% CI, 66.9–79.5) 30.6% (95% CI, 21.7–41.2)
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The pooled procedural success rate (reported in all
included studies) was 99.2% (95% CI, 98.5–99.6). Minor
peri-procedural complication rates were reported in 29
studies with a mean of 3.5% (95% CI, 2.7–4.5). Moreover,
pooled data of 30 studies showed the rate of 1.4% (95%
CI, 1.1–1.9) for major peri-procedural complications
mostly seen using the first generation devices and in early
experiences. Residual shunt rates evaluated by TOE were
reported at different follow-up time points and are summar-
ized in Supplementary Table S2 (online version).
As this initial review included a number of PFO closure
devices which are not used any more, and also some
studies of early experiences with some devices, we per-
formed a subanalysis of PFO closure studies which used
only the most common and current PFO closure devices
(Amplatzer PFO occluder, CardioSEAL family, PFO-Star
family, and Helex), and not early clinical experience.
There were 15 studies (Supplementary Table S2 in online
version)10–15 18–22 24 26 28 29 meeting these criteria. The
success rate was reported in all of them and was 99%
(95% CI, 99.0–99.7). Minor and major peri-procedural
complication rates were reported in 13 studies with the
mean of 4% (95% CI, 2.4–5.6) and 1% (95% CI, 0.7–
1.8), respectively, with seven studies reporting no major
complication.
Discussion
Since the sitting position for neurosurgery was advocated
by De Martel35 in 1931, the debate about its value and
risk has not abated (Table 3). Recently, there has been
a worldwide decline in its use.19 45 74 76 95 A few studies
have shown better neurological outcome and less blood loss
in the sitting position compared with the horizontal
position.2 19 42 92 99 The main reason for not performing
neurosurgery in the sitting position is the risk of PAE
through a PFO. Many authors consider the presence of a
PFO as absolute contraindication for neurosurgical pro-
cedures in the sitting position (Supplementary Table S1 in
online version). However, some neurosurgeons prefer the
sitting position according to their personal results and posi-
tive experience and still perform neurosurgery in the sitting
position even in the presence of a PFO.30 42 47 76 94 107
Our pooled data analysis revealed an overall incidence of
VAE in the sitting position of about 39% in posterior fossa
surgery and 11% in cervical procedures. The reported inci-
dence of PAE during neurosurgical procedures is quite low
in most studies (between 0% and 14%, Table 2).25 33 79 87
Possible reasons for this are avoidance of surgery in the
sitting position in patients with PFO, non-standard and
inaccurate methods of detection (most of the studies did not
search for and detect PAE using intraoperative TOE, and
the report of PAE was only limited to clinically sympto-
matic PAEs), and incomplete data registration. However
rare, PAE can result in severe brain ischaemia and poten-
tially other organ damage.34 48 50 55 78 88 112 118
Relationship between VAE and PAE
In general, the morbidity and mortality of VAE are directly
related to the volume of air entrainment and rate of
accumulation.85 In several animal models, a close relation-
ship between VAE and PAE has been described.29 114 119
However, not every VAE results in PAE, and the clinical
consequences depend on the quantity of air that crosses
over into the arterial circulation.33 Accordingly, great
attention should be paid to minimizing the frequency and
volume of air in any position during surgery, as VAE also
occurs in the horizontal position and in other types of
surgery regardless of the presence of PFO.85 One expla-
nation of the pathophysiology of PAE could be that the
distribution of blood volume between the intra- and extra-
thoracic compartment occurs after a change from the
supine to the sitting position.26 With the number of moni-
toring modalities available, most episodes of VAE are pre-
ventable.39 47 58
As demonstrated in the study of Duke and colleagues,42
the percentage of patients who were monitored intraopera-
tively with TOE or Doppler in the horizontal position was
IVC
RA
SVC
LA
PV
SS
SP
PV
PVPV
Fig 1 Schematic diagram of an Amplatzer PFO occluder placed in a
PFO. The grey area represents endocardium embedding the device within
a few months after the implantation. IVC, inferior vena cava; LA, left
atrium; PV, pulmonary vein; RA, right atrium; SVC, superior vena cava.
Table 3 Advantages of neurosurgery in sitting position5 9 42 92
Improved surgical exposure
Improved anatomical orientation
Improved venous drainage from the surgical field
Better haemostasis
Gravitational drainage of the cerebrospinal fluid and blood from the operative
field
Improved access to the tracheal tube, chest wall, and arms by the
anaesthesiologist
Free diaphragmatic movements
The ability to observe the face for neuromonitoring
Better surgical teaching due to the non-rotated anatomical situation
Shorter surgical time14
Decreased intracranial pressure
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much lower than that in the sitting patients. This underesti-
mates the effective rate of VAE in the horizontal position.
Other factors raising the hazard of VAE are the early stage
of surgery, including muscle preparation and craniotomy,
the use of nitrous oxide (N2O), and the use of PEEP over
5 cm H2O.
2 3 15 Both N2O and PEEP should be used cau-
tiously to minimize further harm by entrained air.17 43 77
Furthermore, a large prospective study found that PEEP
(10 cm H2O) is associated with adverse cardiopulmonary
effects without altering the incidence of VAE.51 This con-
firms an earlier study conducted in paediatric neurosurgi-
cal procedures.83
Methods of detection
Early detection of left-sided cardiac air is vital to prevent
poor neurological outcome and the use of TOE or precor-
dial Doppler is essential in this way.38 77 79 Depending on
the method of detection, the frequency of VAE detection
is up to 70% (Table 1). The most commonly used methods
are TOE, precordial Doppler, E0CO2, right heart catheteriza-
tion, and oesophageal stethoscope in decreasing order of
sensitivity for air detection.16
The potential hazard of PFO
PFO has been increasingly recognized as a source of para-
doxical embolism. The mechanism for this phenomenon is
thought to involve the passage of air, thrombus, or fat from
the right atrium to the left atrium through the PFO and then
on to the systemic circulation.20 36 72 117 As the prevalence of
PFO decreases with age from 35% during the first decade to
20% during the ninth decade of life, a selective mortality
(increased risk of early death in patients with PFO) has to be
considered in addition to spontaneous closure.56 An
additional proof of the prognostic importance is the doubled
mortality risk and the tripled stroke risk of patients with pul-
monary embolism in the presence of a PFO.67
Percutaneous PFO closure with modern closure devices
is the most simple of all catheter-based cardiac interven-
tions. The procedure can be performed as an outpatient
procedure in ,30 min with a fluoroscopy time of ,5 min
and good long-term safety.116 The currently accepted indi-
cations are limited to patients with (recurrent) cryptogenic
stroke, but are likely to expand soon to those with
migraine and divers.
The most commonly used devices so far for PFO
closure are Amplatzer PFO occluder, CardioSEAL family,
and PFO-Star family. Partially bioabsorbable devices
(BioSTAR device), self-expanding stent (Coherex
FlatStent PFO Closure System), and suturing devices
(HeartStich Suturing device) are under clinical investi-
gation. Finally, a radiofrequency energy source for closure
of PFO (PFx Closure System) has been clinically tested
but has not yet reached the market.
The review of percutaneous PFO closure in 5416
patients showed the safety and efficacy of this procedure
in the short and long term with a high procedural success
rate and low morbidity. Consequently, based on the best
available scientific evidence, it is appropriate to consider
percutaneous PFO closure in the preoperative management
of patients requiring neurosurgery in the sitting position.
This is particularly important when PFO is the only
concern, and the sitting position confers a significantly
lower surgical risk (Fig. 2).
Complications
Cerebrovascular ischaemia as a complication during or
after PFO closure is a rare event. Peri-interventional com-
plications were mostly minor, reversible, and decrease
further with experience and device improvement. Some
studies reported no complications with new devices.100 116
Our subanalysis in 15 studies using newer and more
common closure devices showed an overall 3.7% minor
complication rate, and 1.2% major complication rate with
no major complications in half of the studies. Mid- and
long-term complications are also rare and mostly without
clinical significance.82
Residual shunt
Many studies indicate that small PFOs are a very rare
source of paradoxical embolism in patients with crypto-
genic stroke and not clinically relevant.5 62 98 108 110 113
Moreover, Braun and colleagues22 showed that the pre-
sence of a minimal residual shunt after percutaneous PFO
closure cannot be considered as a risk factor for recurrent
Indication for
neurosurgery in sitting
position
Preoperative TOE
Sitting position
No PFO detected
PFO detected
Low surgical risk High surgical risk
SuccessfulDeclined or not
successful
Consider PFO closure
(2–4 weeks before surgery)Horizontal position
Horizontal position Sitting position
Fig 2 Flow chart for PFO closure as a preoperative management in
candidates of neurosurgery in the sitting position.
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thromboembolic events. Hence, the small residual shunt
rate at 1 month in our systematic review of the literature
may not be a matter of concern as these shunts were
mostly trivial, and considered as clinically effective occlu-
sion. Neurosurgery in the sitting position could be safely
performed at that time.
Antithrombotic therapy
Initial antithrombotic therapy after the percutaneous PFO
closure is recommended to prevent device thrombus for-
mation. Although there is no established antithrombotic
therapy regimen and duration after percutaneous PFO
closure, a common regimen is acetylsalicylic acid for 6
months, occasionally accompanied by clopidogrel for 1–3
months. No study has verified the efficacy and necessity of
such antiplatelet therapy. One study10 has shown no
increase in the platelet activation markers after percuta-
neous PFO closure and questioned the necessity of antipla-
telet therapy. Moreover, acetylsalicylic acid has been
prescribed in different dosages in different studies. In a
report of 63 cases with percutaneous PFO closure,64 only
46% of patients were on acetylsalicylic acid and 17% on
anticoagulation therapy after implantation. No device
thrombosis during the mean follow-up period of 2.6 yr
was found. Krumsdorf and colleagues68 did not find any
influence of anticoagulation regimens on device thrombus
formation. Overall, the reported incidence of thrombus for-
mation is low, and in most cases without clinical sequela.
However, there are some differences which favour
Amplatzer and Helex occluders.4 68 116
Endothelialization of different devices for closure of
patent ductus arteriosus in animal models was reported
to start as early as 13 days and to be completed at
5 weeks.54 102 An animal study57 showed partial and com-
plete endothelialization at 1 and 3 months, respectively,
after the implantation of Amplatzer occluders. Early
endothelialization was observed 2 weeks after implantation
of a PFO Star in a patient who underwent surgical explan-
tation of the device due to dislocation.22
For most intra-dural surgical procedures, antithrombotic
therapy should be stopped 7–10 days before surgery and not
recommenced until 1 week after surgery, provided no peri-
operative major bleeding occurs. A significant proportion of
patients who undergo neurosurgical procedures are already
on treatment with aspirin or anticoagulants, and their peri-
operative management is well established. In view of this, it
seems safe to stop acetylsalicylic acid and clopidogrel for
neurosurgery for 2 weeks even early after PFO device
implantation. Ideally, PFO closure should take place at least
2–4 weeks before surgery. In an emergency operation or
when it cannot be delayed, we suggest closure of the PFO
immediately before surgery or to use the horizontal position.
Even the PFO has been closed before operation, techniques
for prevention of air embolism should still be used.85
Conclusions
On the basis of our systematic review, we recommend
screening for PFO and considering PFO closure in cases
where using the sitting position for neurosurgery has
major advantages for the outcome. However, the result of
our systematic review may be limited due to the lack of
data of level A evidence and from using data from cohort
studies with observational nature. Therefore, our proposal
is based on available evidence, and we have proposed a
policy to reduce the risk of PAE and consequently the risk
of neurosurgery in the sitting position in patients with
PFO. The evidence-based recommendations require pro-
spective evaluation in well-designed studies.
Supplementary material
Supplementary material is available at British Journal of
Anaesthesia online.
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